Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recruiting × daromun × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Unknown 2 Not yet recruiting 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 225 Carboplatin 219 Specimen Handling 194 Cisplatin 186 Magnetic Resonance Spectroscopy 164 Radiotherapy 149 Bevacizumab 138 Cyclophosphamide 132 Gemcitabine 129 Drug Therapy 121 Paclitaxel 116 Capecitabine 111 Nivolumab 108 venetoclax 104 Biopsy 103 Oxaliplatin 99 durvalumab 83 Rituximab 81 tislelizumab 80 toripalimab 74 Etoposide 73 Dexamethasone 70 Fluorouracil 68 Docetaxel 67 Pemetrexed 66 atezolizumab 65 Radiosurgery 64 sintilimab 63 Cytarabine 62 Azacitidine 62

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06284590 2024-10-26

INTACT/MeRCI

Philogen S.p.A.

Phase 2 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡